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ABSTRACT
It has been shown that, during the S-phase of the cell
cycle, the mouse DNA methyltransferase (DNA MTase)
is targeted to sites of DNA replication by an amino acid
sequence (aa 207–455) lying in the N-terminal domain
of the enzyme [Leonhardt, H., Page, A. W., Weier, H. U.
and Bestor, T. H. (1992) Cell, 71, 865–873]. In this paper
it is shown, by using enhanced green fluorescent
protein (EGFP) fusions, that other peptide sequences
of DNA MTase are also involved in this targeting. The
work focuses on a sequence, downstream of the
reported targeting sequence (TS), which is homologous
to the Polybromo-1 protein. This motif (designated as
PBHD) is separated from the reported targeting
sequence by a zinc-binding motif [Bestor , T. H. (1992)
EMBO J, 11, 2611–2617]. Primed in situ extension using
centromeric-specific primers was used to show that
both the host DNA MTase and EGFP fusion proteins
containing the targeting sequences were localized to
centromeric, but not telomeric, regions during late
S-phase and mitosis. Also found was that, in ∼10% of
the S-phase cells, the EGFP fusions did not co-localize
with the centromeric regions. Mutants containing
either, or both, of these targeting sequences could act
as dominant negative mutants against the host DNA
MTase. EGFP fusion proteins, containing the reported
TS (aa 207–455), were targeted to centromeric regions
throughout the mitotic stage which lead to the
discovery of a similar behavior of the endogenous
DNA MTase although the host MTase showed much
less intense staining than in S-phase cells. The
biological role of the centromeric localization of DNA
MTase during mitosis is currently unknown.
INTRODUCTION
The mouse DNA methyltransferase (MTase) (3–5) contains a long
N-terminal regulatory domain of >1000 amino acids (aa) and a
shorter C-terminal catalytic domain of 500 aa. An additional 118 aa
peptide at the N-terminus of this enzyme has been described by
Yoder et al. (6) and Tucker et al. (7). The start codon of this newly
defined N-terminus was the only one present in the murine DNA
MTase purified from MEL cells (8). Within the N-terminal domain,
there is a DNA replication foci-targeting sequence (aa 207–455) that
targets the DNA MTase to the sites where its preferred substrate,
hemimethylated DNA, is being synthesized (1). There is a major
phosphorylation site (Ser396) lying in this motif which was
identified in the DNA MTase from the MEL cells (8). Downstream
of this targeting sequence is a short sequence, that has been shown
to bind Zn2+, which is homologous to the zinc-binding motif of
ALL/TRX proteins (4). This is followed by a stretch of sequence
that is homologous to the Polybromo-1 protein (4,9). This
sequence designated as Polybromo-1 protein homologous domain
(PBHD) has 23% identity in a 270 aa overlap with the
Polybromo-1 protein (Liu, unpublished FASTA search). The
function of this sequence motif has not yet been defined.
The distribution of DNA MTase changes dynamically in a cell
cycle-dependent manner (10,11). By immunostaining of NIH3T3
cells with specific antibodies, it has been shown that the mouse
DNA MTase forms toroidal structures in middle and late S-phase
cells. In G1 and early S-phase cells the enzyme showed a diffused
distribution (1). These S-phase toroidal structures were shown, by
in situ hybridization to γ-satellite DNA probes, to be at the
position of centromeric heterochromatin (1).
The B1 sequence (aa 202–369) (containing DNA binding
motifs DB1 and AZn) from the N-terminal domain of human
DNA MTase has both zinc and DNA-binding activity (12) and its
murine homologue (aa 201–377) is included in its known DNA
replication-targeting sequence (12). Constructs over expressing
this targeting sequence may therefore have dominant negative
effects by competing with the endogenous DNA MTase for the
DNA substrate or other factors that recruit the DNA MTase to the
DNA replication foci. Measuring changes in the level of genomic
DNA methylation could assess this effect. Such a dominant
negative mutant could be a useful tool for reducing the level of
genomic DNA methylation, particularly as most human tumor
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cells show elevated levels of DNA MTase (13), a dominant
negative mutant of DNA MTase could be of therapeutic value.
In this study, the tetracycline-regulated system (14) was used
to control the expression of different mouse DNA MTase deletion
mutants. These mutants were made as N-terminal fusions with the
reporter enhanced green fluorescent protein (EGFP) (Clontech)
to provide a fluorescent marker for studying their subcellular
localizations. The effects of the expression of these mutants on the
DNA methylation level of C3H10T were studied by using a
modified SssI methyl-accepting assay (15).
MATERIALS AND METHODS
Materials and plasmids
The EGFP N-fusion series of vectors were purchased from
Clontech. pMC1NeoPolyA which contained the neomycin
resistance gene (neoR) was obtained from Stratagene. Dr K.
Ballmer-Hoffer provided the plasmid pX343 that contained a
hygromycin resistance selectable marker. The autoregulatory
tetracycline regulated expression system (14) was a gift from
Dr D. Pollays (Life Technologies Inc., USA). Oligonucleotides
were synthesized in-house by the FMI oligonucleotide Synthesis
Lab. G418 sulfate was purchased from GibcoBRL. Restriction
enzymes and the Klenow fragment of DNA polymerase I were
obtained from Biofinex. The rapid DNA ligation kit, Taq
polymerase and Texas Red isothiocyanate (TRITC)-labeled
dUTP were purchased from Boehringer Mannheim. Calf intestine
alkaline phosphatase was obtained from NEB. Collagen R
solutions were purchased from SERVA. The secondary anti-
bodies used for indirect antibody staining were purchased from
Sigma and Boehringer Mannheim. BrdU, anti-BrdU monoclonal
antibodies and Hygromycin B were obtained from CalBiochem.
DAPI was purchased from Fluka. All plasmids were prepared
with QIAGEN plasmid Midi kit (Qiagen GmbH).
Construction of EGFP fusion protein expression vectors
Part of the newly discovered N-terminal coding sequence (6–8)
was amplified by PCR using two overlapping oligo-
nucleotides and cloned upstream of the EcoRI site of the reported
cDNA sequence to generate the full length of DNA MTase coding
sequence (Fig. 1, WT). The primers used were:
5′-TCTGTCGCTCGAGTCGCCACCATGCCAGCGCGAACA-
GCTCCAGCCCGAGTGCCTGCGCTTGCCTCCCCGGCAGG-
CTCGCTCCCGGACCATGTCCGCAGGCGGC-3′ (forward
primer) and 5′-TTTGCAGGAATTCATGCAGTAAGTTTAATT-
TTCCCTCACACACTCCTTTTCTGTTAAGCCATCTCTTTC-
CAAGTCTTTGAGCCGCCTGCGGACATGGTCCGGGA-
GC-3′ (reverse primer). The complementary sequence of the above
oligonucleotides and the designed XhoI and EcoRI sites are in bold.
The solutions for PCR amplification consisted of 5 µl 10× PCR
buffer (Boehringer Mannheim), 5 µl 2 mM dNTPs, 2 µl of each
of the above primers (10 µM), 35.5 µl ddH2O and 0.5 µl Vent
polymerase (10 U/µl, New England Biolabs). Amplification was
performed in a Stratagene Robocycler for 30 cycles (94C 1 min,
58C 1 min and 72C 40 s). The amplified fragment (183 bp) was
digested with XhoI and EcoRI and ligated to the XhoI–EcoRI
digested construct 2 (Fig. 1).
The deletion of the earlier reported targeting sequence was
achieved by replacing the NsiI–BglII fragment with the following
short double stranded oligonucleotides containing NsiI and BglII
Figure 1. DNA MTase-EGFP fusion construct maps. The map at the top
represents the full-length wild-type mouse DNA MTase. ‘NN’ refers to the new
N-terminal sequence that has recently been described for the mouse MTase
(6,7) with the numbers underneath in the parenthesis to indicate the start and the
end of this sequence; ‘TS’ is the DNA replication foci-targeting sequence that
was described by (1); ‘Zn’ is the zinc/DNA binding motif (2); PBHD is the
Polybromo-1 protein homologous domain; ‘PC’ is the catalytic site; ‘GK’ is the
linker between the N- and C-terminal domains of DNA MTase and ‘EGFP’
refers to the enhanced green fluorescent protein sequence used as a marker in
the fusion proteins. The black box stands for the intrinsic nuclear localization
signal (aa 72–92) and the green box stands for the NLS of SV40 large T antigen.
The numbers written against the wild-type protein sequence refer to amino acid
positions. The old numbering of the positions of the amino acids is still used
here in order to make comparison with the previous report (2). The numbers
written on the right-hand side of the figure indicate the construct names for each
map and the capital letters in parenthesis correspond to the panels in Figure 2.
Constructs 1–8 were based on the tetracycline-regulated expression system in
which the promoter (Ptet) is controlled by the availability of tetracycline (14).
Constructs 9–11 were based on the EGFP fusion vectors (Clontech) using the
constitutive, human cytomegalovirus immediate early gene (hCMV) promoter.
overhangs without changing any of the surrounding amino acids:
5′-TAGGAAGCTGGTCTATCA-3′ (upper strand) and 5′-ACG-
TATCCTTCGACCAGATAGTCTAG-3′ (lower strand).
Different fragments of the cDNA encoding the N-terminal
domains of DNA MTase were cloned in the N-fusion EGFP
vector (Clontech) (Fig. 1). Those constructs that lacked intrinsic
nuclear localization signals (NLS) had the SV40 T antigen NLS
added, in-frame, to their N-termini. The expression cassettes were
then excised and inserted into the plasmid pTet-Splice down-
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stream of the tetracycline-regulated promoter (Ptet). The constructs
for transient transfection used the constitutive hCMV promoter
rather than the tetracycline-regulated promoter.
Preparation of antiserum against the C-terminal domain of
the mouse DNA MTase
The whole C-terminal domain coding-region of the mouse DNA
MTase was excised as an XhoI–SpeI fragment, blunted by
Klenow and inserted into the blunted BamHI site of the vector
pQE31 (Qiagen) downstream of the 6× His-tag coding sequence.
This construct was expressed in Escherichia coli and the
expressed protein was purified using established protocols
(Qiagen). This recombinant protein was used to immunize rabbits
and the resultant serum was (NH4)2SO4-precipitated as described
by Harlow and Lane (16) to raise the polyclonal antibody against
the C-terminal domain of the mouse DNA MTase (anti-MTC).
Cell culture and stable transfection
Dr A. Baumeister (FMI, Basel) provided the C3H10T cell line. A
subclone called C3.3, which was stable after 15 passages, was used
for the transfections in this study. Transfections were performed
when the cells reached 40–50% confluency. Transient transfections
were performed using SuperFect (Qiagen) according to the
manufacturer’s instructions. Stable transfection of C3.3 cells was
performed using the calcium phosphate procedure (17). The C3.3
cells were co-transfected with the transactivator expression plasmid
pTet-tTAk and the neomycin-resistance plasmid pMC1NeoPolyA
(Strategene). The cells were selected using 600 µg/ml of G418
sulfate for 12 days before the clones were picked up. The cloned
cells were selected at the same concentration of G418 a week
before being tested for transgene expression. Clone TA5, which
stably expressed the transactivator, was used for the second round
of co-transfection using the mutant expression vectors and the
plasmid pX343 carrying hygromycin-resistance gene. Stable
transfectants were selected using 150 µg/ml hygromycin B.
Indirect immunofluorescence
The cells were cultured on 18 × 18 mm microscopy coverslips
(Menzel-Gläser, Germany). Cells were processed 16 h after
induction of expression (stable clones with tetracycline controlled
constructs) or 16 h post-transfection (transiently transfected cells
with constitutive expression constructs). Prior to fixation they
were washed twice in PBS. Fixation was performed by incubating
the cells on ice in 4% fresh paraformaldehyde solution for 30 min.
The paraformaldehyde was removed by two PBS washes and the
cells were then permeablized with 1% Triton-in PBS at room
temperature for 10 min. After two washes with PBS, the cells
were incubated with blocking solution (10% goat serum in PBS)
at room temperature for 30 min followed by incubation with the
fractionated anti-C terminal antibody (1:25 dilution) for 1 h at
room temperature. After three washes with PBS, the cells were
incubated with the secondary antibody using the concentration
suggested by the manufacturer. The cells were then washed three
times with PBS and mounted on glass slides in Vectorshield
(Vector laboratories, Inc., USA) mounting medium.
Conventional and confocal microscopy
Laser confocal microscopic scanning was performed using a
Leica confocal microscope and the SCANWare sofware (Leica).
Conventional microscopic observations for the co-localization of
EGFP fusion proteins and DAPI staining were performed using
a conventional Leica fluorescence microscope.
DAPI staining
Fixed cells were permeablized with 1% Triton X100 in PBS at
room temperature for 5 min and then incubated with 1 µg/ml
DAPI in PBS at room temperature (in the dark) for 10 min and
then washed three times with PBS.
Primed in situ extension (PRINS)
Cells were cultured on collagen-coated 18 × 18 mm coverslips as
described above. Primed in situ synthesis was performed
according to the protocols described in the Boehringer Mannheim
in situ hybridization manual (2nd Edition) using a Perkin Elmer
PCR machine. The chromosomes were labeled by the incorporation
of TRITC-dUTP during the extension of either centromeric- or
telomeric-specific primers by Taq polymerase. The sequences of
the primers were: centromeric-specific (5′-ATTTAGAAATGTC-
CACTGTAGGAC-3′) (18) and telomeric-specific (5′-TTAGG-
GTTAGGGTTAGGG-3′) (19). Indirect immunofluorescence was
performed after the PRINS reaction using an anti-GFP monoclonal
antibody (Clontech) and an FITC-conjugated secondary antibody
(goat anti-mouse, Sigma) to bring up the intensity of the EGFP as
the heating step in the PRINS reaction seriously damaged the
EGFP fluorophore.
Genomic DNA extraction and SssI methyl-group accepting
assay
Cells that were stably transfected with the tetracycline-regulated
constructs (1,4,5,7,8) were passed three times with an overall
induction time of 72 h. Cells were scraped off the culture dishes
using a rubber policeman and their genomic DNA was extracted
according to Sambrook et al. (20). To assess the dominant negative
effect of the DNA MTase–EGFP fusion proteins the genome wide
DNA methylation level was measured using a modified SssI
methyl-group accepting assay (15). Briefly each reaction contained
1 µg of genomic DNA digested to completion by EcoRI, 6 U of SssI
methylase, 2 µM of [3H]S-adenosyl-methionine (SAM) and 18 µM
of cold SAM. After 2 h incubation at 37C, the reactions were
stopped by adding 500 µl 20% TCA using 100 µg BSA as carrier.
The samples were vortexed for 20 s and incubated on ice for
30 min, the precipitates were spun down, washed three times with
20% TCA and hydrolyzed overnight with 100 µl of formic acid.
The samples were then counted for c.p.m. using a scintillation
counter. Every genomic DNA sample was tested in triplicate.
RESULTS
Subcellular localization of EGFP fusion proteins containing
different parts of the N-terminal domain of the DNA
methyltransferase
Stable transfection of C3.3 cells with the full DNA MTase
N-terminal domain, under the control of a constitutive promoter,
was not successful and may be due to the toxicity of this
constitutive expression of the truncated DNA MTase (7). In order
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to obtain a high level of stable expression and to reduce any
possible toxic side effects, a modified tetracycline-regulated
expression system (14) was used. In this system, both the
transgene and the transactivator (the tetracycline repressor-VP16
fusion protein) (21) expression were driven by the tetracycline-
regulated promoter (Ptet) (14). The regulation of expression from
this construct was tested by northern blot hybridization (20). The
EGFP was used as a fusion partner to monitor the expression of
the mutants. The screening of the clones expressing the fusion
proteins was performed as described in the method section.
Fluorescent clones were then cultured on collagen-coated glass
cover slips. Expression was induced for 24 h by changing the
culture medium to tetracycline free medium. Figure 2 shows that
the mutant DNA MTase–EGFP fusion proteins, that included the
DNA replication TS, were all localized to the nucleus and formed
toroidal or spotty structures in S-phase cells similar to those
reported by Leonhardt et al. (1) (Fig. 2C and E–G). Surprisingly,
construct 5, in which two thirds of the reported replication foci
targeting sequence (aa 294–506) had been deleted, also showed
toroidal structures although they were much less abundant
(Fig. 2D). This construct contained the reported zinc-binding
motif (2) and a stretch of sequence homologous to the chicken
Polybromo-1 protein (PBHD, aa574–846) (4,9). Construct 7
(aa 1–138), which did not contain any part of the TS, also showed
the toroidal structures as well as a relatively high level of diffused
localization (Fig. 2B). On the other hand, the nuclear-localized
EGFP alone showed only a diffused nuclear distribution (Fig. 2A)
and the wild-type EGFP showed strong fluorescence in both the
cytoplasm and the nucleus (Fig. 2H). The above results indicated
clearly that, whilst the reported DNA replication foci-targeting
sequence was sufficient to target the EGFP fusion proteins to sites
of DNA replication, other sequences within the protein might also
able to perform this function.
Co-localization of the GFP fusion proteins with the host DNA
MTase showed that the PBHD sequence could also target the
enzyme to DNA replication foci
To test whether or not construct 5 was indeed targeted to sites of
DNA replication, cells were pulse-labeled with BrdU after 16 h
of induction of expression, and stained with an anti-BrdU antibody
as described by Leonhardt et al. (1). Figure 3A (top row) shows
that, in the wild-type cells, host DNA MTase always co-localized
with the incorporated BrdU. Construct 5 co-localized with the
incorporated BrdU (Fig. 3A, bottom row) but was observed in the
same cell as the host DNA MTase at an extremely low frequency
(Fig. 3B, construct 5*) and often showed mutual localization
exclusivity with the host MTase (Fig. 3B, construct 5). While
construct 6 showed a diffused nuclear localization, the host DNA
MTase in the same cell showed toroidal or granular structures
(Fig. 3B). This indicated that the sequence responsible for the
DNA replication foci targeting in construct 5 was lying between
aa 506 and 846, which contains the zinc binding motif and the
PBHD. To further restrict the sequence required for this
localization, three other constructs 9, 10 and 11 (Fig. 1) were
made under the control of the constitutive hCMV promoter. Cells
were transiently transfected and stained with anti-MTC. The
construct 10 showed a diffused nuclear distribution (Fig. 3B)
whereas construct 11 which contained the PBHD sequence
sometimes showed co-localization with the host DNA MTase
similar to construct 5 (Fig. 3B, construct 5*) and sometimes
Figure 2. EGFP fluorescence from the MTase fusion constructs. Cells stably
transfected with the constructs using the tetracycline-regulated expression vectors
were cultured on glass coverslips and induced for expression for 24 h. Confocal
scanning microscopy was performed as described in the Materials and Methods.
The equatorial section for each construct is shown. (A) Construct 8; (B) construct
7; (C) construct 4; (D) construct 5; (E) construct 3; (F) construct 2; (G) construct
1 and (H) construct 12 (wild-type EGFP, controlled by Ptet). The scale bars are
5 µm in length.
showed mutual exclusivity (Fig. 3B, construct 11), that is to say
cells either had strong intensities of EGFP or host MTase staining
but not both (Fig. 3B, constructs 5, 7, 11). The more EGFP
expression observed the less host MTase was found. Construct 9
showed a similar behavior to construct 11 (data not shown). This
indicated that the PBHD was responsible for the DNA replication
foci targeting. Construct 1, which contained the full length of
N-terminal domain of the DNA MTase containing both the TS
and PBHD, showed in general a good co-localization with the
host MTase but in some regions it showed more red (Host MTase)
than green (EGFP) or vice versa (Fig. 3B, construct 1). Construct
4 in some cases showed co-localization with the host MTase and
some times showed mutual exclusivity (Fig. 3B, construct 4). All
of the above results indicate that these MTase–EGFP fusions could
be, in principle, acting as competitors for the host protein on the
DNA binding sites.
DNA MTase was found to be targeted to chromosomal
regions other than just the centromeric regions
We determined the localization of the host MTase and the mutant
MTase–GFP fusions (construct 1, 4, 5 and 9) by immuno-
fluorescence and compared their distributions to those of the
centromeric and telomeric sequences in interphase and S-phase
cells. The localization of the centromeres and telomeres was
made by PRINS reactions using specific primer sets. The
specificity of the PRINS was tested in the following ways:
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(i) single-strand DNA breaks could be blocked by a pre-treatment
with ddNTPs without preventing the PRINS from working;
(ii) the pattern of spots obtained was primer dependent [i.e. no
spots were obtained from cells incubated without primers (data
not shown)]; (iii) PRINS experiments, performed on condensed
chromosomes, showed that the spots obtained with the primers
were localized to the telomeric or centromeric chromosomal
regions (Fig. 4A). The chromosomal localization of the DNA
MTase appeared to be cell cycle dependent, in that ∼10% of the
cells failed to show co-localization with the centromeric regions
(Fig. 4B, constructs 1*, 4*and 5*) whereas the other 90% did
localize (Fig. 4B, constructs 1, 4, 5 and 9). We never observed
telomeric localization of either the host MTase or the EGFP
constructs (data not shown).
To determine the distribution of the EGFP-fusion protein along
the condensed chromosomes, DAPI staining of these cells was
performed. The DAPI-stained cells were observed by conventional
fluorescence microscopy. Figure 4C shows composite images of
green (EGFP) and blue (DAPI) mitotic cells (constructs 1 and 4).
It was clear that the EGFP fusions containing the TS localized to
the structures reminiscent of centromeres during mitosis. Given
the apparent EGFP localization, the question about the location
of the host MTase was addressed by staining untransfected cells
with anti-MTC. DAPI staining was used to visualize the mitotic
chromosomes. Mitotic cells showed a lower staining level of host
MTase than their S-phase counterparts, however, it was clear that
the host MTase did indeed localize to centromeric regions
preferentially (data not shown).
The truncated DNA MTase–GFP fusion proteins can
affect the action of the host DNA MTase in a dominant
negative manner 
The mutual exclusivity between the GFP fusion proteins and the
host DNA MTase indicated that the mutants might exert a
dominant negative effect based on a competition mechanism. The
potential effect of the mutants was assessed by the changes in the
genome-wide DNA methylation of clones stably expressing the
mutants using the SssI methyl-group accepting assay (15). The
assay was designed to carry the reactions to completion. The more
[3H]SAM the DNA samples incorporate, the less methylated they
are. The differences between the incorporation into the control
DNA (isolated from the cells that only express the nuclear-localized
EGFP; Fig. 1, construct 8) and the other constructs tested are
summarized in Table 1. A negative value indicates that the DNA
methylation level is higher than the control and a positive value
Figure 3. Co-localization of host DNA MTase with replication foci and the
MTase–EGFP fusion protein. (A) Shows Br-dUTP incorporation into the
replication foci, in red, of either untransfected (top row) or construct
5-expressing cells (bottom row). Host MTase staining is shown in blue (top row)
and EGFP fluorescence, in green, from construct 5 (bottom row). The-right-hand
column shows composite images of the left and middle columns. (B) Shows
confocal images of the co-localization between the host MTase and the EGFP
fusion constructs. Numbers on left-hand side of the panels stand for the names
of the constructs. 5* shows that, under rare circumstances, construct 5 which
contains mainly the polybromo domain PBHD and a small part of the targeting
sequence TS, indeed co-localized with the host DNA MTase whereas in most
cases it showed mutual exclusivity with the host MTase (Fig. 3B, construct 5).
For constructs 5 and 11 there are two nuclei per panel whereas in all the other
panels there is only one nucleus and as a consequence the magnification of these
two panels is reduced. The scale bars are 5 µm in length.
1043
Nucleic Acids Research, 1994, Vol. 22, No. 1Nucleic Acids Research, 1998, Vol. 26, No. 4 1043
Figure 4. Primed in situ extension (PRINS) detection of centromeric and
telomeric sequences. (A) Shows two control PRINS experiments using either
the centromeric or telomeric primers to demonstrate their specificity. (B) Shows
EGFP expression and centromere-specific PRINS. The numbers on the left are
the construct names. Those marked with a ‘*’ failed to co-localize with the
centromeric PRINS (∼10% of S-phase cells). In (B)9 there are two nuclei
whereas all other panels have only one. (C) Shows EGFP (constructs 1 and 4,
green) localized to the chromosomal structures reminiscent of centromeres. The
right hand panels shows the composite images of the EGFP (green) and DAPI
staining (blue). The scale bars are 5 µm in length.
C
indicates lower methylation. Construct 7 caused a non-significant
(P > 0.05) decrease in the methyl group (CH3) accepting capacity,
whereas the other three constructs (constructs 1, 4 and 5)
significantly increased the CH3 accepting capacity, indicating a
decrease in the level of genomic DNA methylation. The most
extreme case was construct 4, which resulted in the largest degree
of demethylation and also produced the highest and most stable
levels of EGFP fusion protein expression (data not shown). The
delta values were converted into percentage changes of genomic
DNA methylation according to the formulae described in the
legend for Table 1. These changes were 3.8 ± 0.3%, 5.7 ± 0.6%,
2.9 ± 1.7% and 1.0 ± 0.9% for the constructs 1, 2, 4 and 7,
respectively (Table 1, right hand column).
DISCUSSION
Multiple domains are involved in the targeting of the
mouse DNA MTase to the DNA replication foci
DNA MTase–EGFP fusion proteins, which contained the DNA
replication foci TS of the mouse DNA MTase, behaved as
suggested by Leonhardt et al. (1). However, construct 5
(aa 138–294; 507–846), which contained only the first 87 aa of
the TS, and construct 7 (aa 1–138), which did not contain any part
of the TS, also formed the toroidal structures typical for MTase
staining of S-phase cells (Fig. 2B and D). Further analysis showed
that construct 5 also co-localized with the incorporated BrdU
(Fig. 3A, bottom row) and construct 7 showed co-localization
with the host DNA MTase (Fig 3B, construct 7) while the host
DNA MTase always co-localized with the BrdU incorporation
(Fig. 3A, top row). This indicated that, while the TS may be
sufficient for targeting, other sequences in the N-terminal domain
are also involved in this targeting. However, this targeting was not
always equal in efficiency. For example, the fusion proteins
expressed from construct 7 showed both diffused distributions,
reminiscent of the nuclear-localized EGFP control and toroidal
structures similar to those observed from the constructs containing
the published TS. Neither the nuclear-localized EGFP (construct
8) nor the wild-type EGFP (construct 12) controls ever showed
granular structures (Fig. 2A and H). Construct 10 (aa 138–294)
showed a similar diffused distribution as construct 8 while the
host DNA MTase showed granular structures in the same cell.
These data indicate that EGFP targeting to the replication foci
may be performed by the PBHD and the sequence between aa
1–138, albeit less efficiently than the TS. The precise localization
of the EGFP-constructs to replication foci was confirmed by their
co-localization with BrdU (Fig. 3A and B). While these data show
that there is more than one sequence involved in the DNA
replication foci targeting they also show that the TS sequence is
sufficient to fulfil this targeting on its own.
Given the lack of an obvious DNA-binding motif in construct
7, it is possible that it might be targeted to DNA replication sites
via an indirect process such as an interaction with other proteins
or nucleic acids that are themselves targeted to the replication
foci. While as yet we are unable to support or reject this
hypothesis, it should be noted that this protein region is highly
charged and part of the peptide sequence shows high similarity to
the 70 kDa U1 snRNP and to the Su (wa) protein (1). The
construct 5 contained a sequence from the N-terminal part of the
known targeting sequence (aa 207–294, the full length of the TS
is from aa 207–455) which includes the sequences corresponding
to the reported DNA binding motifs DB1 and AZn from the
human DNA MTases (12). However, construct 6 (aa 138–294),
containing the homologous sequences of these motifs, did not
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show any targeting (Fig. 3B) indicating that the DNA binding
activity alone was not sufficient for the targeting. In this paper, we
have restricted the sequence responsible for DNA replication
targeting in construct 5 to the PBHD sequence.
Table 1. Dominant negative effect of the mutants tested using SssI
methyl-group accepting assay
Constructs ∆pmol CH3/µg DNA
8 (reference) 0
1 1.7  0.14
4 2.6  0.28
5 1.3  0.77
7 –0.45  0.39
One microgram of genomic DNA of each clone was used for the SssI methyl-group
(CH3) accepting assay. The incorporated c.p.m. were converted into pmol CH3
accepted per µg DNA. The value of the control sample (Construct 8, the nuclear
localized EGFP) was taken as the basal level (18.1 pmol/µg DNA) and the differ-
ences in the incorporation between other clones to the control were calculated. The
left column shows the constructs tested. The middle column shows the differences
in the incorporation of [3H]CH3 compared with the control (construct 8) ± S.E. The
right hand column shows an estimate of the changes in genomic DNA methylation
assuming that the control cells have 60% of their total CG dinucleotides methylated
at C5 (34). The formulae used for this calculation were as follows: X / Z = 1 – 0.6
and C = (Y – X)/ Z. Where ‘X’ is the amount of [3H]CH3 incorporated into 1 µg of
the control genomic DNA (18.1 pmol in this case). ‘Z’ is the total number of CG
dinucleotides in 1 µg of genomic DNA (45.25 pmol in this case). ‘Y’ is the amount
of [3H]CH3 incorporated into the listed constructs. ‘C’ is the percentage change in
genomic DNA methylation.
The apparent exclusivity between the host MTase and the
‘targeting sequence’ containing EGFP fusion proteins indicated
a competition between these two. Because of this competition, the
relative intensity of the red (host MTase) and green (EGFP-fusion
protein) was dependent on the time at which the transgene was
induced. If it was induced late in S-phase then some of the sites
were presumably already occupied by the host MTase prior to
transgene expression. Thus, when the transgene was expressed it
had much less opportunity to access these sites. However, if the
transgene was expressed at a high level in G1 phase, where the
host MTase is at its lowest level (11), the EGFP fusion protein
would occupy more of the DNA replication foci as the cell cycle
progressed towards S-phase. While this may explain the observed
exclusivity between the host MTase and the EGFP fusion
proteins, potential qualitative differences between these two
could not be excluded. The EGFP fusion proteins that contained
the PBHD and the zinc finger motif, in the absence of the TS,
showed similar localization patterns to construct 5 which
contained only a small part of the TS and the zinc finger motif,
in addition to the PBHD (Fig. 3B, construct 5). They do not,
however, always co-localize with the endogenous DNA MTase
(Fig. 3B, constructs 5 and 11). In many cases the exclusivity
between these PBHD-containing constructs and the host MTase
was stronger than for those containing either the TS alone
(Fig 3B, construct 4) or the TS and PBHD together (Fig 3B,
construct 1). These differences could possibly be explained by the
intrinsic property of PBHD to favor stronger protein–protein
interactions and thus show a stronger sequestration of the
replication machinery.
Chromatin association of the DNA MTase–GFP fusion
proteins
It has been shown that DNA MTase can be associated with
chromatin (22–24). An extensive study of the association of the
MTase–EGFP fusion proteins to the chromatin was performed
using the PRINS techniques with either centromeric or telomeric
specific primers. Consistent with the previous report (1), it was
found that ∼90% of the centromeric PRINS co-localized with the
EGFP fusions containing any of either the TS or PBHD (Fig 4B).
However, it was also found that, in ∼10% of the cells examined,
the EGFP fusions formed granular structures that failed to
co-localize with the centromeric PRINS (Fig. 4B, constructs 1*,
4* and 5*). The satellite DNA sequences located near the
centromeric regions of the mouse chromosomes are heavily
methylated at CpG sites (24) and are replicated at the very end of
S-phase (25–29). After DNA replication, there would be a large
number of hemimethylated sites, therefore, it is not surprising that
a mechanism existing to recruit the DNA MTase to a high
concentration to ensure the methylation pattern faithfully passed
from mother cells to daughter cells. The other 10% of cases may
have reflected genomic regions other than centromeric regions
that also have high concentration of methylated CpG sites.
Although subtelomeric satellite DNA has also been shown to be
heavily methylated in mouse somatic cells (30), we never
observed the EGFP fusion proteins co-localize with the telomeric
PRINS (data not shown).
EGFP-fusion proteins were also found to localize to the
centromeric regions in mitotic cells (Fig. 4C, constructs 4 and 8)
while the nuclear-localized EGFP showed a diffused distribution
at this stage (data not shown). The host DNA MTase showed
lower staining in mitotic cells than in S-phase cells, but it was also
preferentially localized to the centromeres. Although it has been
reported that DNA methylation occurs several hours after
replication (31), it was striking that both the EGFP fusion proteins
and the host MTase were localized to heterochromatic regions
during mitosis. The biological role of this heterochromatic
localization of the DNA needs to be further investigated.
The toxicity of the mutants may be due to the sequestration
of the DNA replication machinery rather than a change in
genomic DNA methylation 
Initial attempts to express mutants, containing the entire N-terminal
domain of MTase, constitutively resulted in no stable-expressing
clones (data not shown). This could be due to the toxic effects of
these DNA MTase mutants as has been discussed by Tucker et al.
(7). Subsequent experiments made use of the autoregulatory
tetracycline-controlled expression system (14) to permit us to
study these potentially toxic proteins.
Because the mutants were targeted to the DNA replication foci, it
is possible that the high levels of their expression might titrate out
several critical components of the DNA replication machinery or
else upset the regulation of DNA replication through the direct
binding of the mutants to genomic DNA. The work of Chuang et al.
(12) revealed the presence of multiple DNA binding motifs in the
N-terminal domain of the human DNA MTase. Tucker et al. (7)
proposed that the toxicity of MTase overexpression might be
attributed to the reported TS. Our construct 4, which contained the
TS and a very short sequence (aa 138–206) upstream of it, was
able to stably overexpress this sequence at a very high level and
could be passed for prolonged periods (2 weeks) without obvious
1045
Nucleic Acids Research, 1994, Vol. 22, No. 1Nucleic Acids Research, 1998, Vol. 26, No. 4 1045
toxic effects whereas any clone containing the PBHD would be lost
in less than a week of passing with a significant loss of fluorescent
cells 24–48 h post-induction (Liu, unpublished observations). Thus
we hypothesize that this apparent toxic effect is most probably due
to PBHD sequence and that its over-expression sequesters critical
components of the DNA replication machinery through protein-
protein interaction resulting in either the loss of the construct or
cell death. This idea of protein–protein interactions is consistent
with the observations that DNA MTase can be tightly bound to the
nuclear matrix (32), possibly for enzyme storage, that it can be
associated with chromatin (22–24) and that it can also interact
with histone H1 strongly (Suetake et al., Poster, FASEB,
Biological methylation, 1997).
The constructs containing the TS and PBHD could serve as
dominant negative competitors for the host DNA MTase and
cause hypomethylation of the genome (Table 1). Construct 4
which expressed the highest level of the fusion protein, showed
the highest effect on the DNA methylation level, but was less
toxic than the others (data not shown) indicating the toxic effect
of the mutants might not be due to the changes in the DNA
methylation level. This was supported by the fact that embryonic
stem cells that had only 1/3 of the genomic DNA methylation
level of the wild-type cells could grow normally (33).
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